[1]

Yang H, Li S, Sun L, et al. Effects of the Ambient Fine Particulate Matter on Public Awareness of Lung Cancer Risk in China: Evidence from the Internet-Based Big Aata Platform[J/OL]. JMIR Public Health Surveill, 2017, 3(4): e64[2018-03-26]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645640/. DOI:10.2196/publichealth.8078.
[2] Shi Y, Sun Y, Yu J, et al. China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer(2016 version)[J]. Asia Pac J Clin Oncol, 2017, 13(1):87-103. DOI:10.1111/ajco.12608.
[3] Osarogiagbon R, Smeltzer M, Faris N. ORAL02.05:Understanding internal differences in N-Category-Stratified non-small cell lung cancer (NSCLC) survival:topic:surgery[J]. J Thorac Oncol, 2016, 11(11S):S255. DOI:10.1016/j.jtho.2016.09.014.
[4] JYY W, Bassig BA, Seow WJ, et al. Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA:The National Lung Screening Trial[J]. Occup Environ Med, 2017, 74(6):440-448. DOI:10.1136/oemed-2016-104168.
[5] Malinovsky G, Yarmoshenko I, Zhukovsky M. Radon, smoking and HPV as lung cancer risk factors in ecological studies[J]. Int J Radiat Biol, 2018, 94(1):62-69. DOI:10.1080/09553002.2018.1399225.
[6] Hart JE. Air pollution affects lung cancer survival[J]. Thorax, 2016, 71(10):875-876. DOI:10.1136/thoraxjnl-2016-208967.
[7]

Salem A, Mistry H, Backen A, et al. Cell death, inflammation, tumor burden, and proliferation blood biomarkers predict lung cancer radiotherapy response and correlate with tumor volume and proliferation imaging[J/OL]. Clin Lung Cancer, 2018, 19(3): 239-248. e7[2018-03-26]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927801. DOI:10.1016/j.cllc.2017.12.002.
[8] Borghetti P, Bonù ML, Roca E, et al. Radiotherapy and tyrosine kinase inhibitors in stage IV non-small cell lung cancer:real-life experience[J]. In Vivo, 2018, 32(1):159-164. DOI:10.21873/invivo.11219.
[9] Klein C, Dokic I, Mairani A, et al. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation[J]. Radiat Oncol, 2017, 12(1):208. DOI:10.1186/s13014-017-0939-0.
[10]

Son B, Jun SY, Seo H, et al. Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer[J/OL]. Sci Rep, 2016, 6: 21986[2018-03-26]. https://www.nature.com/articles/srep21986. DOI:10.1038/srep21986.
[11] Luo H, Liang C. MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1[J]. Exp Ther Med, 2018, 15(4):3609-3616. DOI:10.3892/etm.2018.5845.
[12] Wu SJ, Chen J, Wu B, et al. MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma[J]. J Exp Clin Cancer Res, 2018, 37(1):18. DOI:10.1186/s13046-017-0639-5.
[13] Ajdarkosh H, Dadpay M, Yahaghi E, et al. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues[J]. Diagn Pathol, 2015, 10:135. DOI:10.1186/s13000-015-0371-4.
[14] Gong L, Wang C, Gao Y, et al. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis[J]. Biomed Pharmacother, 2016, 83:58-63. DOI:10.1016/j.biopha.2016.05.049.
[15] Yang JS, Li BJ, Lu HW, et al. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening[J]. Tumour Biol, 2015, 36(4):3035-3042. DOI:10.1007/s13277-014-2938-1.
[16] Li J, Yu T, Cao J, et al. MicroRNA-148a suppresses invasion and metastasis of human non-small-cell lung cancer[J]. Cell Physiol Biochem, 2015, 37(5):1847-1856. DOI:10.1159/000438546.
[17] Ma F, Feng Y, Li W, et al. miR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression[J]. Exp Ther Med, 2017, 13(5):2515-2522. DOI:10.3892/etm.2017.4255.
[18] Rahal Z, El NS, Sinjab A, et al. Smoking and lung cancer:A geo-regional perspective[J]. Front Oncol, 2017, 7:194. DOI:10.3389/fonc.2017.00194.
[19] 董佳丽, 罗丹, 李源, 等.降低B7-H3蛋白对受照肺癌细胞A549细胞周期和凋亡的影响[J].国际放射医学核医学杂志, 2017, 41(3):193-198. DOI:10.3760/cma.j.issn.1673-4114.2017.03.007.
Dong JL, Luo D, Li Y, et al. Study on the effects of B7-H3 down-regulation on cell cycle and apoptosis of lung cancer A549 cells[J]. Int J Radiat Med Nucl Med, 2017, 41(3):193-198.  doi: 10.3760/cma.j.issn.1673-4114.2017.03.007
[20] Kang J, Kim W, Kwon T, et al. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells[J]. Oncotarget, 2016, 7(17):23961-23974. DOI:10.18632/oncotarget.8208.
[21] Chen Y, Min L, Zhang X, et al. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer[J]. Oncol Rep, 2013, 30(4):1832-1840. DOI:10.3892/or.2013.2611.
[22] Onitsuka T, Uramoto H, Tanaka F. Lack of direct association between EGFR mutations and ER beta expression in lung cancer[J]. Anticancer Res, 2011, 31(3):855-860.
[23] Shi S, Tan P, Yan B, et al. ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells[J]. Oncol Rep, 2016, 35(5):2606-2614. DOI:10.3892/or.2016.4680.
[24]

Qiu C, Zhang T, Zhang W, et al. Licochalcone a inhibits he proliferation of human lung cancer cell lines A549 and H460 by inducing G2/M cell cycle arrest and ER stress[J/OL]. Int J Mol Sci, 2017, 18(8): E1761[2018-03-26]. http://www.mdpi.com/1422-0067/18/8/1761. DOI:10.3390/ijms18081761.
[25] Xie WY, Zhou XD, Yang J, et al. Inhibition of autophagy enhances heat-induced apoptosis in human non-small cell lung cancer cells through ER stress pathways[J]. Arch Biochem Biophys, 2016, 607:55-66. DOI:10.1016/j.abb.2016.08.016.
[26] Chen X, Ma N, Zhou Z, et al. Estrogen receptor mediates the radiosensitivity of triple-negative breast cancer cells[J]. Med Sci Monit, 2017, 23:2674-2683.  doi: 10.12659/MSM.904810